Learn More
Upcoming Meetings
SNMMI Therapeutics Conference: Therapies, Theranostics, and Building Your Radionuclide Clinical Practice
October 25-27, 2019 | Las Vegas, Nevada
Book Your Hotel | Agenda | Register
Explore the Latest Innovations in Therapy
This two-and-a-half-day conference explores the latest innovations in therapy, including acquiring the knowledge and resources to effectively deliver theranostics agents and the fundamental steps necessary to establish a nuclear medicine therapy program at your institution.
Healthcare Provider
Welcome to our Healthcare Provider portal. Everything you need to understand the advantages and applications of nuclear medicine and molecular imaging in your practice. Find out more about ordering the right test for the right patient at the right time.
- What's New
- Disease-Specific Information
- Guidelines
- Ordering Information
- Other Resources
- Request a Speaker
SNMMI's Newly Approved Appropriate Use Criteria
Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process. To view the development process, please click the following link: SNMMI AUC Development Process.
NEW AUCs:
- Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
- Hepatobiliary Scintigraphy in Abdominal Pain
- FDG PET/CT Restaging and Response Assessment of Malignant Disease
- Bone Scintigraphy in Prostate and Breast Cancer
- Ventilation/Perfusion (V/Q) Imaging in Pulmonary Embolism
Disease-Specific Information
Oncology |
Cardiology
|
Neurology
|
Guidance
SNMMI has created guidelines to identify those elements of the procedure that are most important in obtaining a high-quality examination, Appropriate Use Criteria (AUC), and is working towards optimizing dose.
Guidelines
Appropriate Use Criteria
Dosimetry
Dose Optimization
Related Resources
NCCN's Guidelines Tabular Summary
NCCN Practice Guidelines Narrative Summary
Ordering Information
The SNMMI PET Center of Excellence has created a go-to resource with in-depth ordering information and printable materials related to PET and PET/CT, including:
-
Sample Request Forms
-
Sample Letters of Medical Necessity
-
Sample Reports from Nuclear Medicine Physician
-
CMS Decision Memos
Learn More
Other Resources
Request a Speaker
SNMMI is dedicated to providing the community with access to the most knowledgeable and experienced speakers in the field of nuclear medicine and molecular imaging. As part of the new Outreach Program, SNMMI is working to enhance relationships with relevant societies and patient organizations. We have created a pool of speakers who can speak at your next meeting. Please complete the form below to request a speaker.
Outreach Speaker Request Form
Outreach Program
FAQs
- July 17, 2019 —
Bipartisan Group Moves to Expand Access to Diagnostic Radiopharmaceuticals
On July 16, a bipartisan group introduced the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (HR 3772). The bill would expand patient access to highly targeted, precision diagnostic radiopharmaceuticals that evaluate conditions such as Alzheimer’s disease, Parkinson’s disease, and some cancers—allowing patients to get the right treatment faster and saving taxpayers money.
(Press Release) - June 27, 2019 —
Influence of The Journal of Nuclear Medicine Jumps 25 Percent
The Journal of Nuclear Medicine again ranks among the top five medical imaging journals in the world. JNM continues to lead among nuclear medicine journals, with the highest impact factor (7.354), the highest immediacy index, the highest number of citations, the highest 5-year impact factor, the highest number of citable articles, and the highest influence score.
(Press Release) - June 25, 2019 —
New Combination Therapy Established as Safe and Effective for Prostate Cancer
A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects.
(Press Release) - June 25, 2019 —
Ultrasmall Nanoclusters and Carbon Quantum Dots Show Promise for Treating Acute Kidney Injury
Two research studies offer hope for effective treatment and prevention on acute kidney injury.
(Press Release)
- Jun 13, 2020 -
Jun 16, 2020
—
SNMMI 2020 Annual Meeting
New Orleans Ernest N. Morial Convention Center
Headquarter Hotel: New Orleans Marriott Downtown | New Orleans | - Jan 28, 2021 -
Jan 30, 2021
—
SNMMI 2021 Mid-Winter Meeting
Hyatt Regency San Francisco | San Francisco | - Jun 12, 2021 -
Jun 15, 2021
—
SNMMI 2021 Annual Meeting
Walter E. Washington Convention Center
Headquarter Hotel: Marriott Marquis Washington, DC | Washington | - Jun 11, 2022 -
Jun 14, 2022
—
SNMMI 2022 Annual Meeting
Vancouver Convention Centre
Co-Headquarter Hotels: Fairmont Waterfront and Pan Pacific | Vancouver | Canada - Jun 8, 2024 -
Jun 11, 2024
—
SNMMI 2024 Annual Meeting
Metro Toronto Convention Centre
Headquarter Hotel: Fairmont Royal York | Toronto | Canada
Featured Resources
- Legislative Issues
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
- Celebrate Women in Medicine Month
- Radiation Safety+ Review and Essentials
- Clincal Guidelines
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
- Nuclear Medicine and Molecular Imaging Week: October 6-12, 2019
Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.